Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Trulieve Cannabis Corp C.TRUL

Alternate Symbol(s):  TCNNF | C.TRUL.NT.U

Trulieve Cannabis Corp. is a vertically integrated cannabis company. The Company has established cannabis operations in three hubs: Southeast, Northeast, and Southwest. Its three regional hubs are anchored by market positions in cornerstone states of Florida, Pennsylvania, and Arizona. The Company operates in regulated markets that require knowledge in cultivation, manufacturing, and retail. The Company utilizes various extraction techniques, including critical ethanol extraction, carbon dioxide extraction, hydrocarbon extraction, and mechanical separation. In addition, the Company owns and utilizes carbon dioxide extraction, distillation, purification and manufacturing technology that is used to produce a range of cannabis topicals and vapes featuring cannabinoids. The Company's brands include premium tier brands Avenue, Cultivar Collection, and Muse; mid-tier brands Modern Flower, Alchemy, Momenta, and Sweet Talk, and value tier brands Co2lors, Loveli, Roll One, and Trekkers.


CSE:TRUL - Post by User

Post by retiredcfon Oct 24, 2021 7:51am
248 Views
Post# 34041725

Assessment

AssessmentQ: I own VFF, GTII, CURA, TRUL and VRNO (5% of the portfolio and down about 8% to date). What is interesting is that recent broker targets overall are substantially higher. Are these recommendations worth considering and what is your assessment of this list ... while I wait for recovery or US to pass SAFE?

We like TRUL, VFF and CURA the most here, but would consider it a decent list. In terms of target prices, we would take these with a large grain of salt. Brokers still hope to get business and are probably being aggressive. CURA, for example, has an average target at more than 100% of current prices. 

So said the team at 5iResearch. GLTA
 
<< Previous
Bullboard Posts
Next >>